Transdermal “Natural GLP-1” Dietary Supplements Violate Law and Place Patients at Risk
- 2 January 2026
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 60 (8) , 813-816
Abstract
Consumers precluded from obtaining semaglutide or tirzepatide by clinicians or insurers are turning to natural “GLP-1” transdermal patches. The Dietary Supplement Health and Education Act specifies dietary supplement products must be swallowed, so all these products are illegal. We identified 24 transdermal patch dietary supplement products and 1 transdermal gel product with an average of 7 ± 4 natural ingredients (berberine, glutamine/glutamate, cinnamon, and pomegranate most listed). No certificates of analysis were posted, many products lacked the Food and Drug Administration disclaimer, and many products used deceptive advertising. Several products had 1- to 2-star reviews and consumer comments suggesting lack of efficacy or adverse events.Keywords
This publication has 15 references indexed in Scilit:
- Visualizing the transdermal delivery of berberine loaded within chitosan microneedles using mass spectrometry imagingAnalytical and Bioanalytical Chemistry, 2024
- Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide “For Research Purposes”Annals of Pharmacotherapy, 2024
- GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatmentBMJ, 2024
- The effects of pomegranate consumption on obesity indices in adults: A systematic review and meta‐analysisFood Science & Nutrition, 2023
- What Should Dietary Supplement Oversight Look Like in the US?AMA Journal of Ethics, 2022
- Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021The Journal of Clinical Pharmacology, 2022
- The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trialsClinical Nutrition ESPEN, 2020
- Dietary Supplements Pose Real Dangers to PatientsAnnals of Pharmacotherapy, 2020
- Berberine induces GLP-1 secretion through activation of bitter taste receptor pathwaysBiochemical Pharmacology, 2015
- Glucose Tolerance, Lipids, and GLP‐1 Secretion in JCR:LA‐cp Rats Fed a High Protein Fiber DietObesity, 2008